Nanoviricides Inc (NNVC)
2.23
+0.43
(+23.89%)
USD |
NYAM |
May 16, 16:00
2.15
-0.08
(-3.59%)
After-Hours: 20:00
Nanoviricides Cash from Investing (Quarterly): -0.0055M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.0055M |
| September 30, 2023 | -0.0083M |
| June 30, 2023 | -0.0026M |
| March 31, 2023 | -0.0593M |
| December 31, 2022 | -0.0453M |
| September 30, 2022 | -0.0445M |
| June 30, 2022 | -0.0754M |
| March 31, 2022 | -0.0393M |
| December 31, 2021 | -0.1853M |
| September 30, 2021 | -0.0243M |
| June 30, 2021 | -0.0846M |
| March 31, 2021 | -0.1106M |
| December 31, 2020 | -0.0086M |
| September 30, 2020 | -0.035M |
| June 30, 2020 | -0.0045M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | -0.0041M |
| June 30, 2019 | -0.0097M |
| March 31, 2019 | -0.0066M |
| December 31, 2018 | -0.0203M |
| September 30, 2018 | -0.0373M |
| June 30, 2018 | -0.0166M |
| March 31, 2018 | -0.1327M |
| December 31, 2017 | -0.0621M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.0304M |
| June 30, 2017 | -0.0464M |
| March 31, 2017 | -0.0942M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | -0.0244M |
| June 30, 2016 | -0.0521M |
| March 31, 2016 | -0.0608M |
| December 31, 2015 | -0.0298M |
| September 30, 2015 | -0.3337M |
| June 30, 2015 | -1.196M |
| March 31, 2015 | 0.7492M |
| December 31, 2014 | -4.751M |
| September 30, 2014 | -0.5625M |
| June 30, 2014 | -0.6129M |
| March 31, 2014 | -1.260M |
| December 31, 2013 | -0.084M |
| September 30, 2013 | -3.274M |
| June 30, 2013 | -0.0649M |
| March 31, 2013 | -1.00M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | -0.00 |
| March 31, 2012 | -0.0112M |
| December 31, 2011 | -0.0183M |
| September 30, 2011 | -0.0291M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.1853M
Minimum
Dec 2021
--
Maximum
Dec 2019
-0.0393M
Average
-0.0243M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 20.81M |
| Enanta Pharmaceuticals Inc | 58.62M |
| GlycoMimetics Inc | -0.0074M |
| FibroGen Inc | 51.28M |
| Corvus Pharmaceuticals Inc | -0.007M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.719M |
| Free Cash Flow | -6.203M |
| Free Cash Flow Per Share (Quarterly) | -0.1468 |
| Free Cash Flow Yield | -23.79% |